A Calsequestrin-1 mutation associated with a skeletal muscle disease alters sarcoplasmic Ca2+ release by D'Adamo, Maria Cristina et al.
RESEARCH ARTICLE
A Calsequestrin-1Mutation Associated with a
Skeletal Muscle Disease Alters Sarcoplasmic
Ca2+ Release
Maria Cristina D’Adamo1, Luigi Sforna1, Sergio Visentin2, Alessandro Grottesi3,
llenio Servettini1, Luca Guglielmi1, Lara Macchioni1, Simona Saredi5, Maurizio Curcio5,
Chiara De Nuccio2, Sonia Hasan1, Lanfranco Corazzi1, Fabio Franciolini4, Marina Mora5,
Luigi Catacuzzeno4*, Mauro Pessia1,6*
1 Section of Physiology & Biochemistry, Department of Experimental Medicine, University of Perugia School
of Medicine, Perugia, Italy, 2 Department of Cell Biology and Neuroscience, Istituto Superiore di Sanità,
Roma, Italy, 3 SuperComputing Applications and Innovation–CINECA, Roma, Italy, 4 Department of
Chemistry, Biology and Biotechnology, University of Perugia, Perugia, Italy, 5 Neuromuscular Diseases and
Neuroimmunology Unit, Foundation IRCCS Neurological Institute C. Besta, Milano, Italy, 6 Department of
Physiology & Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
*mauro.pessia@unipg.it; mauro.pessia@um.edu.mt (MP); luigi.catacuzzeno@unipg.it (LC)
Abstract
An autosomal dominant protein aggregate myopathy, characterized by high plasma crea-
tine kinase and calsequestrin-1 (CASQ1) accumulation in skeletal muscle, has been
recently associated with a missense mutation in CASQ1 gene. The mutation replaces an
evolutionarily-conserved aspartic acid with glycine at position 244 (p.D244G) of CASQ1,
the main sarcoplasmic reticulum (SR) Ca2+ binding and storage protein localized at the ter-
minal cisternae of skeletal muscle cells. Here, immunocytochemical analysis of myotubes,
differentiated from muscle-derived primary myoblasts, shows that sarcoplasmic vacuolar
aggregations positive for CASQ1 are significantly larger in CASQ1-mutated cells than con-
trol cells. A strong co-immuno staining of both RyR1 and CASQ1 was also noted in the vac-
uoles of myotubes and muscle biopsies derived from patients. Electrophysiological
recordings and sarcoplasmic Ca2+ measurements provide evidence for less Ca2+ release
from the SR of mutated myotubes when compared to that of controls. These findings further
clarify the pathogenic nature of the p.D244G variant and point out defects in sarcoplasmic
Ca2+ homeostasis as a mechanism underlying this human disease, which could be dis-
tinctly classified as “CASQ1-couplonopathy”.
Introduction
A surplus of endogenous proteins within circumscribed areas of muscle fibers often character-
izes protein aggregate myopathies. Moreover, chronically elevated plasma creatine kinase (CK)
is a common feature of these myopathies and may precede clinical presentation. Patients from
several Italian families with hyperCKaemia and clinical myopathy, whose muscle biopsies
showed pathological features and sarcoplasmic inclusions positive for the SR Ca2+ binding/
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storage protein calsequestrin-1 (CASQ1), have been previously described [1,2]. The main clini-
cal features of these patients were myalgia, muscle cramps or mild muscle weakness, and mild
to moderate elevation of serum CK. Recently, a heterozygous missense mutation in the CASQ1
gene, involving an evolutionarily-conserved residue of the CASQ1 protein (p.D244G), has
been identified [3,4]. Nevertheless, the pathophysiological mechanisms related to this mutation
remain mostly unclear.
In mammals, two CASQ isoforms are expressed in skeletal muscle and the heart [5].
CASQ1 is the only isoform expressed in fast-twitch skeletal muscle, and the major isoform
expressed in slow-twitch skeletal muscle. CASQ2 is the sole isoform expressed in cardiac mus-
cle and represents a minor component of slow-twitch skeletal muscle [6]. The low affinity, high
capacity Ca2+-binding protein CASQ1 is concentrated within discrete areas of the muscle SR,
such as in the terminal cisternae, where it buffers large amounts of Ca2+. The close proximity
of these CASQ1 concentrated areas to ryanodine release channels allows for the easy release of
this Ca2+ pool to the surrounding cytosol giving rise to the [Ca2+]i increases that sustain con-
traction. To support this, CASQ1 ablation in mice results in reduced levels of SR Ca2+ release
and in altered contractile properties [7,8].
In the present study, we carried out functional investigations of CASQ1-D244G showing
that this missense mutation alters the expression pattern of CASQ1 in patient derived myo-
tubes and decreases the release of Ca2+ from the SR. This inherited skeletal muscle disease,
involving a component of the couplon [9], could be distinctly called “CASQ1-couplonopathy”.
Methods
Myotubes cell cultures
Patient specimens were obtained from the biobank directed by Dr.Marina Mora. Written,
informed consent was obtained from the subjects or their parents/legal guardians. Research
was conducted according to protocols approved by the Institutional Review Board of the Besta
Neurological Institute and University of Perugia, and in compliance with the Helsinki Declara-
tion and local legislation. Control muscle cell cultures were obtained from patients suspected
of neuromuscular disease, but who had normal muscle on biopsies and no CASQ1mutations.
Primary myoblasts were derived directly from biopsied material by culturing in Dulbecco's
modified Eagle’s medium (DMEM; Lonza Group Ltd, Basel, Switzerland) containing 20%
heat-inactivated fetal bovine serum (FBS) (Gibco Life Technologies), 1% penicillin-streptomy-
cin (Lonza), L-glutamine (Lonza), 10 μg/ml insulin (Sigma Aldrich, St. Louis, MO), 2.5 ng/ml
basic fibroblast growth factor (bFGF) (Gibco Life Technologies), and 10 ng/ml epidermal
growth factor (EGF) (Gibco). The medium was changed twice weekly and the cultures exam-
ined by inverted-phase microscopy. At 70% confluence they were dissociated enzymatically
with trypsin-EDTA (Sigma) and seeded for immediate propagation, or frozen in medium con-
taining 10% DMSO (Sigma) for later propagation or other use.
To obtain myotubes, the myoblasts were seeded into 35 mm dishes or in chamber slides in
DMEM proliferating medium. At 70% confluence, proliferating medium was changed to differ-
entiating medium (DMEM, 1% penicillin-streptomycin, L-glutamine and insulin, without FBS
or growth factors) and the myoblasts were allowed to differentiate into myotubes over 7–9 days
[10].
Immunocytochemistry
Myotubes were fixed in methanol, permeabilized in PBS plus 0.15% Triton-X100 (Bio-Rad,
Hercules, CA, USA), for 15 min, incubated in 3% BSA (Bovine serum albumin, Sigma Aldrich,
Saint Louis, MO, USA) in PBS for 30 min, followed by a 120 min incubation in anti-CASQ1
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(polyclonal antibody Abcam, Cambridge, UK) diluted 1:500 in PBS and 60 min incubation in
Alexa Fluor 488 goat anti-rabbit IgG (Molecular probes, Carlsbad, CA, USA) diluted 1:1500 in
PBS. All incubations were carried out at room temperature. In patient muscle, CASQ1 was co-
localized with RYR1 following incubation of sections with polyclonal anti-CASQ1 (Abcam;
1:500) plus monoclonal anti-RYR1 (Thermo Fischer Scientific, Waltham, MA USA; diluted
1:10), followed by incubation with Alexa Fluor 488 goat anti-rabbit IgG (Molecular Probes Inc,
Eugene, OR, USA), and successively by incubation with Alexa Fluor 546 goat anti-mouse IgG
(Molecular Probes). Cells and muscle sections were examined under a Zeiss fluorescence
microscope or a Leica confocal microscope equipped with hybrid and argon lasers.
Quantitations of CASQ1-positive puncta
CASQ1-positive puncta were quantitated by using ImageJ 1.47 software (http://rsb.info.nih.
gov/nih-image/), on pictures of myotubes from 2 patients and 2 controls, taken at 60x magnifi-
cation. Briefly, by using the software, a threshold was applied to each picture to obtain black
and white images, with areas positive for CASQ1 puncta in black and areas negative in white.
The total area occupied by the CASQ1-positive puncta was measured and divided by the num-
ber of puncta present in the picture to calculate the average area of puncta. A total of 87 pic-
tures from control and 133 from patient cultures were evaluated. Manual corrections were
sometimes applied to eliminate non-myotube/non-CASQ1 punctum areas recognized by the
software. The ratio of total area of puncta in a myotube to myotube area (determined as men-
tioned above) was also calculated, in which case 40 control and 40 patient myotubes were eval-
uated. Blind measurements were performed by two independent observers.
Western blotting
40 μg of protein extracted from myotube cultures at 10 days were loaded in a gradient precast
gel 4–15% (Bio-Rad) and transferred onto nitrocellulose membranes (Schleicher and Schuell
Inc., Keene NH, USA). Membranes were probed with one of the following antibodies: mouse
monoclonal anti-caveolin 3 (BD Biosciences, Franklin Lakes, New Jersey), diluted 1:2500 and
used as an indicator of how much muscle protein was loaded; rabbit polyclonal anti-CASQ1
(Abcam) diluted1:1000; and mouse monoclonal anti-Ryanodine receptor (Thermo Fischer Sci-
entific) diluted 1:800. An appropriate biotin-conjugated secondary antibody was then applied
(Jackson ImmunoResearch, West Grove, PA, USA), followed by peroxidase-conjugated strep-
tavidin (Jackson ImmunoResearch), and detection with SuperSignal West Pico Trial kit
(Thermo Fischer Scientific). Western blot bands were quantitated densitometrically using Ima-
geJ, and normalized to caveolin 3 bands in duplicates of cultures from two patients and two
controls.
Molecular modeling and visualization
The structure of the CASQ1 molecule was modelled using, as starting point, the crystal struc-
tures of human [11] (PDB code: 3UOM) and rabbit [12] (PDB code: 3TRQ) CASQ1. The
D244G mutation was generated in silico using VMD software (Visual Molecular Dynamics).
Further molecular structure optimization was performed by energy minimization procedure as
described previously [13]. For structural comparison with experimental data, a new crystal
structure of the human D244G mutant at high Ca2+ concentration was used [14] (PDB code:
5CRG). Root mean square deviation (RMSD) of the CASQ1 fold between our model of D244G
and the new crystal structure was 1.75 Å (Cα positions). In particular, superimposition of the
mutation site gave the lowest RMSD (0.195 Å) when the residue range 241–265 was used.
CASQ1-Couplonopathy
PLOS ONE | DOI:10.1371/journal.pone.0155516 May 19, 2016 3 / 14
Electrophysiological studies on myotubes
Action potentials (APs) were recorded from myotubes by using the whole-cell configuration of
perforated patch under current-clamp mode. Typically, a hyperpolarizing current injection (in
the -200 to -800 pA range; 500 ms duration) followed by a pulse to zero current elicited
rebound APs. In order to assess the AP shape, the following parameters were determined: Vr:
resting membrane potentials; APampl: action potential amplitude (AP voltage peak minus Vr);
APdur: action potential duration at half amplitude; AHPampl: after-hyperpolarization ampli-
tude; AHPdur: after-hyperpolarization duration at half amplitude. Depolarization-evoked tail
currents (SK currents) due to small conductance Ca2+-activated K+ channels were obtained
from perforated patch, whole-cell voltage-clamp recordings of myotubes derived from 3
patients and 3 controls after culturing myoblasts in differentiation medium for 7–9 days.
Recordings were performed as previously described [15]. Currents and voltages were recorded
with a HEKA EPC-10 amplifier (List Medical, Darmstadt, Germany) and analyzed with the
Patch Master package (version 2X60, Elektronik) and Origin 8.0 software (Microcal Software,
USA). Macroscopic currents were filtered at 3 kHz and sampled at 100 μs intervals. SK current
densities (ratio of current to capacitance pA/pF) were calculated 0.5 s after the onset of the
repolarization pulse back to -40 mV, which was preceeded by depolarizing pulses that lasted 1
s. Depolarizing pulses were increased in 20 mV steps, starting at -40mV and ending at +120
mV. The selective SK channel blocker apamin was used to assess whether the tail current was
mainly due to SK channels. The external solution was (mM): NaCl 106.5, KCl 5, CaCl2 2,
MgCl2 2, MOPS 5, glucose 20, Na gluconate 30, pH 7.25. The internal solution was (mM):
K2SO4 57.5, KCl 55, MgCl2 5, MOPS 10, pH 7.20. Electrical access to the sarcoplasm was
achieved by adding amphotericin B (200 μM) to the pipette solution. Access resistances in the
range 15–25 MΩ were achieved within 10 min from seal formation, and were actively compen-
sated to about 50%. All chemicals were analytical grade. Amphotericin B (50 mM) (Alomone
Labs Jerusalem, Israel) was dissolved in DMSO to make stock solutions which were prepared
daily. Maximum DMSO concentration in the working solutions used was about 0.1%. Separate
application of 0.1% DMSO had no significant effect on membrane currents. Experiments were
carried out at room temperature (18–22°C).
Measurement of sarcoplasmic Ca2+ signals
Depolarization-induced Ca2+ signals. Measurements of the sarcoplasmic Ca2+ signals
evoked by a depolarizing stimulus were performed using the video imaging recording tech-
nique with Fluo-4 AM Ca2+ indicator (Invitrogen) in combination with patch-clamp. Fluo-4
AM was dissolved in DMSO at a concentration of 1 mM. Myotubes, differentiated from myo-
blasts on poly-lysine-coated Petri dishes, were loaded with Fluo-4 AM (5 μM) by incubation in
the dark at 37°C (30 min) using an incubation solution having the following composition (in
mM): 140 NaCl, 5 KCl, 2 CaCl2, 2 MgSO4, 10 glucose, and 5 MOPS, pH 7.4, supplemented
with 0.05% bovine serum albumin. Myotubes were then placed under an inverted microscope
(Axio observed D1, Zeiss) and the patch-perforated configuration was achieved using the
methods and solutions described above. CdCl2 100 μMwas added to the extracellular solution
10 min before starting the experiments. After selecting the myotube in phase contrast visual
field and establishing the perforated patch configuration, an excitation wavelength of 494 nm
was continuously applied by means of a mercury short-arc lamp and the emitted light (510
nm) was recorded by a CCD digital camera (AxioCam ICm1) connected to a computer. Ca2+
transients obtained by stimulating the myotube with a 2 s long depolarizing stimulus from -60
to +80 mV were recorded. The MatLab software (MathWorks) was used for image analysis,
consisting of mean pixel intensity assessment of a selected region of the patch-clamped
CASQ1-Couplonopathy
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myotube. Origin 8.0 software (Microcal Software, USA) was used for further analysis and
graphical presentation. Fluorescence changes were expressed as the ratio (F/F0) of the emitted
fluorescence intensity (F) to that recorded just before the depolarizing stimulus (F0).
Caffeine-induced Ca2+ signals. Sarcoplasmic Ca2+ was also measured using the Fura-2
AM Ca2+ indicator (Invitrogen) in combination with video imaging. Fura-2 AM (2.5 mM) was
sonicated for 5 min in Pluronic ac/DMSO (1/4) to make a stock solution. Myotubes, differenti-
ated from myoblasts on poly-lysine-coated glass coverslips, were loaded with Fura-2 AM by
incubation in the dark (50 min) with 2.5 μM Fura-2 AM dissolved in recording buffer (see
below) at room temperature. The myotubes on coverslips were placed in the perfusion cham-
ber on the stage of an inverted microscope (Axiovert 35, Zeiss, Germany) and perfused with
buffer (mM: 140 NaCl, 5 KCl, 1 MgCl2, 5.5 D-glucose, 10 HEPES/NaOH, room temperature,
pH 7.4). Solutions containing various concentrations of caffeine were made using the buffer
and replacing NaCl with caffeine in the ratio of 2:1 to maintain osmolarity. A rapid solution
exchanger (Bio-Logic, France) allowed the solution bathing the cells to be switched rapidly
between control and test solutions. After selecting myotubes in bright visual field they were
illuminated at 340 and 380 nm (Polychrome II, Photonics, Germany) and the emitted light
(510 nm) was recorded by a CCD digital camera (PCO, Sensicam, Germany) connected to a
computer.
The Imaging Workbench software (INDEC Systems, CA, USA) was used for recording and
initial data analysis. Origin 8.0 software (Microcal Software, USA) was used for further analysis
and graphical presentation. Ca2+ concentrations were expressed as the ratio of emissions at 340
nm to 380 nm. Ca2+ signal amplitudes were calculated as maximum amplitude during caffeine
challenge minus baseline amplitude recorded prior to challenge.
Statistics
Data are presented as means ± SEM. The significance of differences between groups was inves-
tigated by Student’s t-test, and the following levels of significance noted:  p<0.05;  p<0.01;
 p<0.001.
Results
CASQ1-positive aggregates in myotubes carrying the D244Gmutation
To establish a cellular model suitable to investigate the mechanisms underlying this CASQ1--
couplonopathy in a physiological setting, primary myoblasts were derived directly from biop-
sied healthy subjects (WT) and patients carrying the D244G mutation and allowed to
differentiate into myotubes (Fig 1A). Immunocytochemical analysis of cell samples showed
that the average area of CASQ1-positive puncta was significantly larger in patient than control
myotubes (0.039±0.015 μm2 vs 0.031±0.008 μm2; p<0.001; Fig 1B). The average ratio of total
area of puncta in a myotube to myotube area was also significantly greater in patient than con-
trol cells (0.031±0.02 vs 0.02±0.01; p<0.05; Fig 1C).
Immunocytochemical staining of RyR1 and CASQ1 in patient and control myotubes
showed that both proteins co-localized within puncta (Fig 2). A strong co-immuno staining of
both RYR1 and CASQ1 was also noted in the vacuoles of muscle biopsies derived from patients
(Fig 2).
Densitometric analysis of the immunoblot bands of protein extracted from myotube cul-
tures showed that CASQ1 values were higher in patient samples compared to controls (1.12
±0.21 vs 0.62±0.48, respectively), whereas, values for RyR1 bands were similar (0.26±0.22 vs
0.21±0.11, respectively). Collectively, these data indicate that patient-derived cultured myo-
tubes recapitulate distinct morphological features of diseased adult muscle fibers, namely, a
CASQ1-Couplonopathy
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broader presence of CASQ1 aggregates, as we have previously shown by confocal microscopy
analysis of samples biopsied from the same patients [3], and the co-expression of RYR1 and
CASQ1 in muscle vacuoles (Fig 2).
Structural analysis of WT and mutated CASQ1
Based on the available data from the crystal structure of human CASQ1 [11], we located the
aspartate residue at position 244 and used in silicomutagenesis to replace it with glycine (Fig
3). The model indicated that a Ca2+ ion is coordinated by both the carbonyl oxygen of the pep-
tide backbone and the glutamate carboxylic acid (Fig 3B). This was corroborated by analyzing
the X-ray structure of rabbit CASQ1 [12] (not shown). Nearby glutamate (E251) and proline
(P246) also contributed to Ca2+ coordination (Fig 3B). Substitution of glutamate by glycine
(D244G) did not obviously alter the ability of the backbone carbonyl oxygen to coordinate Ca2
+, yet it eliminated the carboxylic side-chain and its contribution to Ca2+ coordination (Fig
3C). A recent study reported the crystal structure of the D244G mutant [14]. Using this new
experimental data (Fig 3D), we validated our model superimposing the two structures (model
Fig 1. Sarcoplasmic inclusions of CASQ1 in myotubes. (A) Immunocytochemical staining of
CASQ1-positive puncta in control (left panel) and patient (right panel) myotubes (scale bar = 10 μm). (B)
Averaged area of CASQ1-positive puncta in control and patient myotubes expressed as: total area of puncta
(μm2)/n°of puncta. (C) Average ratio of CASQ1-positive puncta in control and patient myotubes expressed as
total area of puncta (μm2)/total area of myotube (μm2). The data are mean±SEM (*p<0.05, ***p<0.001).
doi:10.1371/journal.pone.0155516.g001
CASQ1-Couplonopathy
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and crystal structure; Fig 3E) and corroborated our initial prediction on the structural effect of
the D244G mutation. Indeed, the RMSD of the Cα carbon atoms of the superimposed homol-
ogy model and crystal structures for D244G resulted in a 1.75 Å difference in the overall struc-
ture, whilst at the mutation site the structural difference was 0.195 Å (residue ranging from
241–265). We have also compared the RMSD of the Cα carbon atoms of the D244G model
with that of WT X-Ray structure and found that the model differed 1.20 Å in the overall struc-
ture and 0.163 Å in the region where the mutation is located (residue ranging from 241–265)
(Fig 3F). Ovearll, this analysis indicated that the conformation of the homology model and
crystal structure in the region of interest is highly similar. Furthermore, these results and pub-
lished data suggest that the D244G mutation may alter sarcoplasmic Ca2+ homeostasis,
although this remains an open question.
Assessments of electrophysiological properties of myotubes
To investigate D244G-induced dysregulation of sarcoplasmic Ca2+ homeostasis we first vali-
dated patient derived myotubes as an appropriate model to study the pathogenic mechanisms
underlying CASQ1-couplonopathy. Perforated patch-clamp recordings from patient and con-
trol myotubes were performed to establish their basic electrophysiological properties and assess
Fig 2. Confocal images of CASQ1 and RYR1 co-localization in both myotube andmuscle biopsy.
Immunocytochemical staining of RYR1 and CASQ1 in patient (upper panels) and control myotubes
(intermediate panels; scale bar = 10 μm). The lower panels show CASQ1 and RYR1 co-staining in vacuoles
of fibers derived from a patient muscle biopsy (scale bar = 50 μm).
doi:10.1371/journal.pone.0155516.g002
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for cell ability to generate rebound all-or-none action potentials (APs), followed by after-hyper-
polarization, an index of proper cell differentiation [16]. Fig 4A shows representative APs
recorded in current-clamp mode from aWT and D244G myotube, when stimulated by a
hyperpolarization-induced current prepulse followed by a step to zero current injection. Analy-
sis of several electrophysiological parameters revealed no statistically significant differences
between the resting membrane potential (Vr) and the APs recorded fromWT and D244G cells
(Table 1).
In voltage-clamp mode, 1 sec depolarization pulses at +20 mV activated outward currents,
which were followed by slowly decaying tail-currents upon returning to -40 mV (Fig 4B).
The decaying currents were markedly inhibited by apamin, a selective blocker of Ca2+-acti-
vated K
+
channels of the SK type (Fig 4B, enlarged traces). We next examined the level of sur-
face expression for SK channels in normal and mutated myotubes by using ionomycin, a
potent Ca2+ ionophore and, DCEBIO an enhancer of SK channels. To attain both maximal
intracellular Ca2+ concentration and full activation of SK channels, 2 μM ionomycin (in the
presence of extracellular Ca2+), and 100 μMDCEBIO were co-applied onto myotubes. This
procedure resulted in membrane hyperpolarizations of similar degrees in both WT and
D244G myotubes (Fig 4C and 4D). These tests showed that some basic electrical properties
of myotubes differentiated from either healthy subjects or patients were similar further sup-
porting the myotube as an appropriate model to study the pathogenic mechanisms underly-
ing this myopathy.
Fig 3. Molecular modeling of CASQ1. (A) Ribbon representation of a CASQ1monomer (the red spheres
indicate the D244 residue). (B) Close up view of the region of interest in WT protein. A Ca2+ ion (green
sphere) is coordinated by the carbonyl oxygen of the backbone and the carboxylic acid group of the side
chain of aspartate 244 (oxygen atoms and water molecule are shown as red and yellow spheres,
respectively). Two other residues (glutamate E251 and proline 246) also coordinate the same Ca2+. (C)
Homology modelling of CASQ1 in which the aspartate 244 was replaced by a glycine (see Methods). (D)
Crystal structure of CASQ1 carrying the D244Gmutation determined by X-Ray diffraction (see text) [13]. (E)
Superimposition of the homology model (grey) and the crystal structure (red) for CASQ1-D244G protein. (F)
Superimposition of the homology model (grey) and the crystal struxcture (red) for CASQ1-WT protein (the
arrow indicates the residue D244).
doi:10.1371/journal.pone.0155516.g003
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Fig 4. Recordings of action potentials and SK type Ca2+-activated K+ currents frommyotubes. (A) Rebound
APs elicited by a hyperpolarizing current (-600 pA, 500 ms), followed by a pulse to zero current injection, in sample
myotubes from a patient (red) and a control (black). (B) Currents, elicited in a control myotube by a pre-pulse to +20
mV, followed by repolarization to -40 mV. Tail currents are shown enlarged before (ctrl) and after apamin (apa)
application (100 nM). The bar graph (inset) shows the fractional tail current before and after apamin application. (C)
Membrane voltage traces recorded from sample control (black) and patient (red) myotubes, showing the
hyperpolarizing effect of co-application of 100 μM of the SK channel activator DCEBIO and 2 μM of the Ca2+
ionophore agent ionomycin (indicated as DCEBIO/iono) in the recording chamber, without applying holding current.
(D) Plot showing the mean membrane potential before (Vr) and after (Vr2) bath application of DCEBIO/iono, and the
mean DCEBIO/iono induced hyperpolarization (ΔV) in control (black) and patient (red) myotubes. The data are mean
±SEM; n = 6.
doi:10.1371/journal.pone.0155516.g004
Table 1. Action potential parameters assessed from control and D244Gmyotubes.
PARAMETERS CTRL D244G P (CTRL vs D244G)
Vr (mV) -48.5±7.1 (5) -53.1±3.2 (5) 0.5777
APampl (mV) 62.5±6.2 (5) 63.8±3.0 (5) 0.8516
APrt (ms) 11.58±0.5 (5) 11.5±1.5 (5) 0.9485
AHPampl (mV) 5.8±1.0 (5) 5.5±2 (5) 0.8921
AHPdur (ms) 74.6±11 (4) 61.8±12 (4) 0.4707
Abbreviations: Vr: resting membrane potentials; APampl: action potential amplitude; APdur: action potential
duration; AHPampl: after-hyperpolarization amplitude; AHPdur: after-hyperpolarization duration at half
amplitude. The data are means±SEMs; the number of observations is indicated in parenthesis.
doi:10.1371/journal.pone.0155516.t001
CASQ1-Couplonopathy
PLOS ONE | DOI:10.1371/journal.pone.0155516 May 19, 2016 9 / 14
Effects of D244Gmutation on SR Ca2+ release upon electrical
stimulation
We took advantage of surface expression of SK channels in myotubes and exploited them as
sensors of intracellular Ca2+ to explore whether the D244G mutation in CASQ1 alters SR Ca2+
release under near physiological conditions (i.e., electrical stimulation). Patch-clamp record-
ings of slowly decaying SK tail currents were performed to address this issue. Analysis of SK
tail currents showed that they were significantly smaller in patient than control myotubes at
most depolarized potentials (Fig 5A–5C). SK currents, recorded under these experimental con-
ditions, may be however activated by both Ca2+ influx through plasma membrane voltage-
gated Ca2+ channels and Ca2+ release through RyR channels involved in excitation-contraction
coupling. To isolate SK currents, activated by SR’s release of Ca2+ through RyR channels, Cd2+
was applied to inhibit Ca2+ influx through plasma membrane Ca2+ channels. Under these con-
ditions SK tail current densities measured from patient myotubes were still significantly smaller
than those measured from controls (Fig 5D–5F). Altogether these data suggested that the p.
D244G mutation reduces SR Ca2+ release during excitation-contraction coupling.
Fig 5. SK tail current densities in control vs D244G expressing myotubes. Sample tail currents elicited
by pre-pulse potentials from -40mV to +120mV and recorded at a holding potential of -40 mV from control (A,
black traces) and D244G expressing (B, red traces) myotubes. (C) Tail current densities, calculated from
control (open circles) and D244G (red circles) myotubes and, plotted as a function of pre-pulse potentials.
Sample tail currents recorded as described above in the presence of Cd2+ (100 μM), from control (D, black
traces) and D244G (E, red traces) myotubes. (F) Tail current densities in the presence of Cd2+ (100 μM) that
were recorded, calculated and plotted as described in C. Data reported in plotsC and F were obtained from 3
independent experiments (n = 6; *p<0.05; **p<0.01; ***p<0.001).
doi:10.1371/journal.pone.0155516.g005
CASQ1-Couplonopathy
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The D244Gmutation reduces Ca2+ signals from myotubes
To provide more direct evidence concerning the effect of the mutation on the amount of Ca2+
released from the SR through RyR channels, during the excitation-contraction coupling, we
measured Ca2+ signals resulting from a brief voltage-clamp step delivered through the patch
pipette that depolarized the myotube to +80 mV (Fig 6). In the presence of CdCl2 (100 μm), to
inhibit Ca2+ influx through plasma membrane Ca2+ channels, depolarization of a control myo-
tube elicited a Ca2+ signal that reached a peak and decayed to basal level after several seconds
(Fig 6A). Remarkably, depolarization of myotubes carrying the D244G mutation resulted in
much smaller peak Ca2+ signals compared to control (Fig 6B and 6C).
Ca2+ signals resulting from application of the RyR agonist caffeine on myotubes were also
measured. As shown in Fig 7, exposure of patient myotubes to increasingly elevated levels of
extracellular caffeine resulted in Ca2+ transients that were of significantly lower amplitude than
those induced in control myotubes.
Discussion
Patients carrying the D244Gmutation present with a myopathy characterized by one or more
symptoms that include episodes of muscle cramping, mild myalgia, muscle weakness, fatigue,
and hyperCKaemia. Here, we have presented results that prove that Ca2+ dynamics, vital for
normal muscular function, are altered and underlie this D244Gmyopathic phenotype.
The substitution of the highly conserved aspartate amino acid for glycine, at position 244 of
the CASQ1 polypeptide, results in CASQ1 protein aggregation that manifests as vacuolar inclu-
sions that stain positive for CASQ1 [3]. We have previously shown by means of immunohis-
tochemistry, electron microscopy and electrophoretic investigations that CASQ1 was present
in greater quantities in the muscle fibers of patients carrying the mutation when compared to
that of control subjects, and that the mutated CASQ1 was responsible for the abnormal
CASQ1 inclusions [3]. Here we report that myotubes derived from patients also recapitulate
this distinct feature of the disease, namely, the formation of CASQ1 vacuolar aggreagates. In
addition we also point out that both CASQ1 and RyR1 coexist in muscle vacuoles, an
Fig 6. Sarcoplasmic Ca2+ signals elicited by depolarization in control vs D244Gmyotubes. Representative fluorescence traces elicited by
depolarization to +80 mV (in the presence of CdCl2 100 μM) from Fluo-4AM-loaded control (A, CTRL) and patient (B, D244G) myotubes. The voltage-clamp
steps applied to myotues are shown below each sample trace. (C) Bar graph showing the mean Ca2+ signals elicited from control (black) and D244G (red)
myotubes (the data are mean±SEM; n = 5; ***p<0.001).
doi:10.1371/journal.pone.0155516.g006
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observation that might be pathophysiologically relevant. Our previous electrophoretic studies
showed that the mutated protein does not migrate in the same way as the normal protein and
displays the tendency to form complexes [3]. This finding is consistent with the tendency of
D244G protein to aggregate abruptly and abnormally, in vitro [14].
The carbonyl oxygen atom of Asp244 (the residue mutated in our patients), along with that
of Pro-246 and the carboxylate of Glu-251, form a high-affinity Ca2+ coordination site in the
CASQ1 protein (Fig 3) [11]. Our structural model of native and mutated CASQ1, showing that
the substitution of Asp-244 with the more flexible Gly destabilizes a Ca2+ coordination site, is
fully consistent with the recently reported CASQ1-D244G crystal structure [14]. Lewis and col-
leagues also showed that crystallized D244G under low Ca2+ concentrations resulted in a disor-
dered lattice lacking the linear back-to-back interaction characteristic of CASQ1. Under high
Ca2+ concentrations sufficient for Ca2+ binding into the coordination site, the lattice regained
order, however without the normal back-to-back contact. The D244G-induced abnormal
CASQ1 polymerization and aggregation, and the presence of larger amounts of mutated
CASQ1 protein stored in intracellular organelles of diseased muscles (Figs 1 and 2) [3], could
lead to sarcomere destabilization and cell toxicity that may eventually contribute to some of
the associated muscular symptoms of the disease, such as elevated plasma CK. The overall con-
dition is however clinically mild possibly because compensatory mechanisms/proteins inter-
vene to ensure near normal muscle functionality.
The D244G-induced disruption in CASQ1 polymerization may also affect Ca2+ diffusion
towards the open Ca2+ release channels by altering the local concentration of diffusible Ca2+
ions, their one-dimensional directionality or CASQ1-RyR allosteric interactions, overall reduc-
ing RyR-mediated Ca2+ release from the SR as documented in this study. It has been shown
that CASQ1 inhibits RyR channels, depending on its phosphorylation status and whether it is
bound to RyR directly or indirectly via anchoring proteins [9,17], all of which could be altered
as a consequence of the associated structural change in CASQ1.
Fig 7. Sarcoplasmic Ca2+ signals elicited by caffeine in control vs D244Gmyotubes. Representative fluorescence images from
fura-2-loaded control (A) and patient (B) myotubes before (CTRL) and during caffeine application (Caff 10 mM). Sample traces showing
signals elicited by caffeine (Caff 3, 10, 40 mM) and recorded frommyotubes derived from controls (C) and patients (D). (E) Bar graph
showing the mean Ca2+ signals elicited by different caffeine concentrations from control (black) and D244G (red) myotubes. Data are
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That in this study, patient-derived myotubes had large CASQ1 aggregates, greater in area
than that in myotubes derived from control subjects and similar to that observed from patient
muscle biopsies, make myotubes differentiated from biopsied primary myoblasts an appropri-
ate model to investigate the pathogenic mechanisms underlying this CASQ1-couplonopathy.
Having basic electrophysiological properties comparable to healthy myotubes is consistent
with the clinically mild phenotype of the disease and further strengthens the usefulness of this
model. Activated by and dependent on intracellular Ca2+, the SK current makes a useful, albeit
indirect, functional assessment tool for investigating mechanisms that underlie SR calcium dys-
function. The reduced SK tail-current densities measured from patient myotubes is functional
proof that the mutation results in a physiologically significant reduction in Ca2+ release from
the SR. A more direct evidence lies in the results from the Ca2+ signal recordings where myo-
tube depolarization evoked Ca2+ signals of lower amplitude than those evoked in control myo-
tubes. Also the exposure to increasingly elevated levels of caffeine, an RyR agonist, resulted in
significantly lower Ca2+ transients in patient myotubes. Consistently, the SK tail-current acti-
vation results, both from depolarization- and caffeine-induced Ca2+ signals, indicate that the
CASQ1’s p.D244G mutation disrupts normal muscle function by compromising SR Ca2+
release via RyR channels. Noteworthy, caffeine has been widely used to deplete the SR of Ca2+
[18], and the amplitude of caffeine-induced Ca2+ transients is commonly taken as an index of
the SR Ca2+ load [19]. Our observations suggesting that D244G could also affect the loading
capacity of the SR (i.e., the amount of Ca2+ sequestered by mutated CASQ1), is consistent with
data showing that the D244G protein possesses a lower binding capacity in vitro, and that the
aggregates are less able to bind Ca2+ [14].
Overall, the evidence provided here further implicates D244G substitution as pathogenic
and points out defects in Ca2+ homeostasis within muscle fibers as a possible mechanism
underlying muscle cramping, weakness and fatigue. With a much clearer understanding of the
D244G mutation and its effect on altering sarcoplasmic Ca2+ release, the major challenges to
be tackled in the near future would be a better understanding of the mechanisms leading to
D244G-induced cell toxicity and designing possible therapeutic interventions for this newly
identified CASQ1-couplonopathy.
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